NBIX
129.31 USD
-1.37%
Today
-2.14%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 11:00 PM
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
Neurocrine Biosciences Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
13.17B
Avg Daily Volume
1.04M
52 Week High
160.18 USD
52 Week Low
84.23 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.
Top News
Arista
+1.12%
Broadcom
+4.79%
BakerHghs
-0.92%
Caseys
-2.66%
CFIndustries
+1.73%
CVSCare
+0.82%
Chevron
-0.53%
Elevance-Health-Inc
-2.02%
EnergyTransfer
+0.63%
Flagstar.Financial
-0.78%
GeneralDyn
-2.65%
Halozyme
+1.00%
Humana
-2.52%
Intel
+1.02%
Levi.Strauss
+0.00%
Cheniere
-0.08%
MercadoLbr
-1.16%
Neurocrine
-2.14%
OldDominion
-0.58%
Oneok
+0.24%
VirginGalactic
+1.69%
UnitedHlt
-0.66%
Valero
+1.57%
Williams
-0.12%
ExxonMobil
-1.24%
BUZZ-U.S. STOCKS ON THE MOVE-UnitedHealth, Intel, Apple
reuters.com
3d ago
Arista
+1.12%
Broadcom
+4.79%
BakerHghs
-0.92%
Caseys
-2.66%
CFIndustries
+1.73%
CVSCare
+0.82%
Elevance-Health-Inc
-2.02%
GeneralDyn
-2.65%
Halozyme
+1.00%
Humana
-2.52%
MercadoLbr
-1.16%
Neurocrine
-2.14%
OldDominion
-0.58%
VirginGalactic
+1.69%
UnitedHlt
-0.66%
BUZZ-U.S. STOCKS ON THE MOVE -Health insurers, Arista, Savara
reuters.com
4d ago
Neurocrine
-2.14%
BTCUSD
-0.63%
US STOCKS-Wall St ends higher as investors parse US-Iran negotiations, threats
reuters.com
4d ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
